Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Vanflyta

(van-FLIH-tah)
A drug used with certain chemotherapy drugs and then alone as maintenance therapy to treat adults with newly diagnosed acute myeloid leukemia that has a certain mutation in the FLT3 gene. It is also being studied in the treatment of other types of cancer. Vanflyta blocks FLT3 and other proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called quizartinib dihydrochloride.
Search NCI's Dictionary of Cancer Terms